Associations of GDF-15 and GDF-15/adiponectin ratio with odds of type 2 diabetes in the Chinese population

被引:9
|
作者
Wu, Xiaoying [1 ]
Xuan, Wenting [2 ]
You, Lili [1 ]
Lian, Hong [1 ]
Li, Feng [1 ]
Zhang, Xiaoyun [1 ]
Chen, Qingyu [3 ]
Sun, Kan [1 ]
Chen, Chaogang [1 ]
Xu, Mingtong [1 ]
Li, Yan [1 ]
Yan, Li [1 ]
Zhang, Xiuwei [2 ]
Ren, Meng [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, 107 Yanjiang West Rd, Guangzhou 510120, Peoples R China
[2] Dongguan Peoples Hosp, Dept Endocrinol, 3 South,Xinguyongwan Rd, Dongguan 523059, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Boji Healthcare Ctr, 107 Yanjiang West Rd, Guangzhou 510120, Peoples R China
关键词
Growth differentiation factor-15; Adiponectin; GDF-15; adiponectin; Type; 2; diabetes;
D O I
10.1007/s12020-021-02632-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose We elucidate the effect of Growth differentiation factor-15(GDF-15)/adiponectin ratio in improving the assessment value for odds of type 2 diabetes. Methods Cross-sectional design. A total of 405 participants (135 patients with newly diagnosed type 2 diabetes, 135 age- and sex-matched participants with prediabetes, and 135 healthy controls) were collected from Guangzhou and Dongguan, China. The serum GDF-15 and adiponectin levels were measured by ELISA and latex-enhanced immunoturbidimetry. Logistic regression analysis and restricted cubic splines were used to evaluate the associations between diabetes and the indicators. Results The low level of adiponectin and high GDF-15/adiponectin ratio were significantly associated with increased odds of type 2 diabetes, but not for GDF-15. Three clusters were identified based on the K-means clustering analysis. Compared to the lowest quartiles of adiponectin, the OR and 95% CI of the highest adiponectin with type 2 diabetes was 0.24 (0.07-0.74, p trend = 0.004) after adjusting for sex, age, BMI, and DBP only in cluster 1. After adjusting for confounding factors, subjects with the highest GDF-15/adiponectin ratio quartiles had 3.9 times (OR = 3.85, 95% CI = 0.76-24.25) and 3.8 times (OR = 3.80, 95% CI = 1.02-14.68) higher odds of type 2 diabetes in cluster 2 and cluster 3, respectively. The association between the GDF-15/adiponectin ratio and type 2 diabetes was attenuated, but still remarkable (OR = 3.18, 95% CI = 1.11-10.18), in cluster 1. Conclusions Higher GDF-15/adiponectin ratio is independently associated with increased odds of type 2 diabetes for all study populations, suggesting that the GDF-15/adiponectin ratio may be a better indicator of type 2 diabetes.
引用
收藏
页码:423 / 436
页数:14
相关论文
共 50 条
  • [11] GDF-15 and colorectal cancer. Comparison between GDF-15, CA19.9 and CEA AT diagnosis
    Castillo Perez, C.
    Tahiri Bachiri, N.
    Rodriguez Alonso, L.
    Cebrian Ballesteros, M.
    Torrubia Dodero, B.
    CLINICA CHIMICA ACTA, 2024, 558 : 27 - 28
  • [12] Growth differentiation factor 15 (GDF-15) in endocrinology
    Pedro Iglesias
    Ramona A. Silvestre
    Juan J. Díez
    Endocrine, 2023, 81 : 419 - 431
  • [13] Growth differentiation factor 15 (GDF-15) in endocrinology
    Iglesias, Pedro
    Silvestre, Ramona A.
    Diez, Juan J.
    ENDOCRINE, 2023, 81 (03) : 419 - 431
  • [14] Targeting GDF-15 in cancer cachexia and immunity
    Cheng, Louise Y.
    Desai, Jayesh
    Neeson, Paul J.
    NATURE MEDICINE, 2025, : 1069 - 1070
  • [15] GDF-15 in Pulmonary and Critical Care Medicine
    Verhamme, Fien M.
    Freeman, Christine M.
    Brusselle, Guy G.
    Bracke, Ken R.
    Curtis, Jeffrey L.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2019, 60 (06) : 621 - 628
  • [16] GDF-15 and risk stratification in atrial fibrillation
    Marin, Francisco
    Roldan, Vanessa
    NATURE REVIEWS CARDIOLOGY, 2015, 12 (01) : 8 - 9
  • [17] GDF-15 and risk stratification in atrial fibrillation
    Francisco Marín
    Vanessa Roldán
    Nature Reviews Cardiology, 2015, 12 : 8 - 9
  • [18] GDF-15 in emergency patients with acute dyspnea
    Slagman, A.
    Searle, J.
    Holert, F.
    Bruening, A.
    Vollert, J. O.
    Muller, R.
    Datwyler, S.
    Mueller, C.
    Mockel, M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 476 - 477
  • [19] The cardiovascular risk marker GDF-15 predicts cancer incidence in patients with type 2 diabetes
    Novak, J.
    Pavo, N.
    Wurm, R.
    Neuhold, S.
    Adlbrecht, C.
    Vila, G.
    Strunk, G.
    Clodi, M.
    Resl, M.
    Brath, H.
    Luger, A.
    Pacher, R.
    Huelsmann, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S276 - S277
  • [20] GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
    Adela, Ramu
    Banerjee, Sanjay K.
    JOURNAL OF DIABETES RESEARCH, 2015, 2015